German University

WASHINGTON & BERLIN--( BUSINESS WIRE )--A new website from the Association of Medical Device Reprocessors promises to be a one-stop-shop for all information related to the regulated practice of reprocessing single-use medical devices (SUDs). Available at either www.ResponsibleReuse.org or www.AMDR.org , the site is designed with simple navigation and actionable information for health and environmental policy makers, hospital supply chain purchasers, researchers, journalists, and anyone else who is interested in reducing costs, waste and greenhouse gas emissions in the health sector. The new website is a response to the spike in interest in medical device reprocessing as a low-hanging fruit for hospitals to lower costs and achieve emission reduction goals. In 2022, AMDR serviced a record number inquiries from policy makers, journalists, and researchers from the US and Europe. Resources available include AMDR’s first published policy agenda, new infographics for global and US-only production and use of reprocessed SUDs (and other resources for journalists), and a “Sustainability Standard” template for hospitals and national policy makers seeking to create a uniform policy on the use of reprocessed devices. The homepage also links to in-depth pages exploring concepts about reprocessing, including: “ A Moral Imperative for Healthcare Professionals ” to reduce their environmental footprint Reducing Costs by Reprocessing Growing the Circular Economy in the Health Sector Strengthening the Supply Chain The Right to Repair Medical Devices Best Practices from Top Reprocessing Hospitals What to do if you Want to Start Reprocessing medical devices Why “Single Use” Does not Always Mean “Use Only Once” when it comes to medical devices The site also includes media and social media resources, news releases, a glossary of relevant terms, and a bibliography of nearly all peer-reviewed research on reprocessing going back to the 1980s. All of this and more is organized sleekly and intuitively – amounting to a one-stop hub for all-things reprocessing. “The medical device reprocessing industry goes back more than twenty years,” said Daniel J. Vukelich, President and CEO of AMDR. “Back then, the research was all about safety and cost-savings, and of course it was all in stacks of paper. Today, with massive interest and commitments to address the dual threats of COVID and climate change, the volume of news, research, data – you name it – coming out about reprocessing in one month now exceeds that of a whole year back when we built our previous website. We are pleased to offer this comprehensive resource. About the Worldwide Commercial Reprocessing Industry Reprocessing, known as “remanufacturing” in Europe, is well regulated and practiced in 19 countries. Pioneered in the United States with strong regulation from the Food and Drug Administration, the industry has grown from roughly $20 million in 2000 to over $460M in 2021. Over 10,500 hospitals and surgical centers, including all US News & World Report “Top Hospitals,” all U.S. military hospitals, and 23 German University hospitals used reprocessed SUDs in 2021. If all U.S. hospitals used reprocessed devices at the rate of the top 10% performing hospitals (in terms of the number of devices they reprocess), U.S. hospitals would save nearly $2.5 trillion. [All data courtesy of www.AMDR.org ]. About AMDR The Association of Medical Device Reprocessors is the global trade association for the regulated, commercial single-use device reprocessing and remanufacturing industry. For 23 years, AMDR has promoted reprocessing and remanufacturing as an important healthcare strategy that helps hospitals and healthcare providers increase quality, reduce costs, waste and emissions, and strengthen the supply chain. AMDR protects the interests of its members in regulation, legislation and standard-setting. AMDR members include Arjo ReNu Medical, Innovative Health, Medline Renewal, NEScientific, Stryker Sustainable Solution, Sustainable Technologies (a Cardinal Health Business), and Vanguard AG. Having played a key role in the establishment of the reprocessing industry, AMDR continues to push the global medical technology industry, leading the way for remanufacturing to play a defining role in the evolution of new device technologies.

While telemedicine is often hailed as a way to give patients care in the home, it’s also being used to help emergency services treat patients with more information. In Germany, research university Technische Hochschule Mittelhessen has zeroed in on helping providers use telehealth in emergency services. Sean O’Sullivan, a researcher at Technische Hochschule Mittelhessen, will be speaking at HIMSS21 about his team’s work in the field. “At the end of 2017, we started our research in telemedicine in Emergency Medicine. Having started from scratch, we were able to quickly develop scientifically based solutions and presented these at the opening ceremony of the Telemedicine and E-Health Competence Center in Giessen, Germany in April 2018. By using a simple, but practical and easy-to-integrate approach for our digital health solutions we received a lot of positive feedback.” Researchers then began to test out the service in various locations and regions. O’Sullivan said that his team saw uses for the technology in emergency departments and emergency medical service vary based on available staff, infrastructure, rural or urban setting and level of expertise of various providers. “We focused not on developing new skyrocketing technologies, but, by understanding local medical processes and trying to support current medical pathways digitally, we saw that asking patients, providers and administrators was a better strategic way for developing solutions that can make a relevant difference in the way medicine is being provided,” O’Sullivan said. Currently, the researchers are beginning larger trials in different medical settings in order to research which tech works best in what setting and location, as well as who would be the best end users. “As these are the relevant questions to understand and develop individual medical solutions while regarding scalability, costs and international application,” he said. The focus is getting patients quality care faster and figuring out the best care option for patients. “In our trials, we saw that using telemedicine allowed patients and paramedics to connect early with physicians, not only with emergency departments or clinical specialists, but also with local physicians or GPs. This allowed hospitals to focus their capacities on critically ill [patients] that needed hospitalization, while other noncritical patients could stay at home, be treated there, and could be visited by their GP. "The pandemic showed us that the solutions and ideas we provided were the right ones and the use of such technology can improve treatment.” Sean O’Sullivan will share more thoughts during his HIMSS21 session, "A Low-Cost Concept for Telemedicine in EMS in Giessen." It's scheduled for Tuesday, August 10, 4-5 p.m., in Venetian, San Polo 3404. */ /*-->*/ HIMSS21 Coverage An inside look at innovation, education, technology, networking and key events at HIMSS21 Global Conference & Exhibition in Las Vegas.

LONDON--(Marketwire - January 11, 2010) - Medical Care Technologies, Inc. (OTCBB: MDCE) today announced that Minh Nguyen was elected as an Advisory Board Member to the Company. Ms. Nguyen brings extensive knowledge of business, as well as experience in several industries, including international business trade, and products. Ms. Nguyen has more than 17 years of experience in start-ups and management. Ms. Nguyen graduated from Hanoi Foreign Languages University in English and French Studies in 1992 and Business and Finance Management from Hanoi Economic University in 1994. Ms. Nguyen started out her career working as a Business Coordinator for the Vietnam Chamber of Commerce in Hanoi (1992-1994), assisting Vietnamese business enterprises in maintaining trade relations with other countries. Ms. Nguyen was responsible for promoting and protecting Vietnamese businesses and their interests in Vietnam as well as abroad. Her other responsibilities included promoting and assisting in their trade and investment, their economic and technological co-operation, as well as other business activities in Vietnam and abroad. From 1995-2000, Ms. Nguyen took on the role of Director of Hanoi Trading Company of Hanoi, Vietnam. Her responsibilities included supervising and coordinating activities of workers engaged in inspecting materials to ensure adherence to the company's quality standards and customer specifications. From 2000-2005, Ms. Nguyen was an independent consultant and imported and exported textile products between China and Vietnam. Located in Hanoi, she served as the business liaison for businesses in Shanghai, China and Hanoi, Vietnam. From 2005-2008, Ms. Nguyen was an independent consultant, acting as the liaison for tourism and trade between Vietnam and Europe. Based in Shanghai, her responsibilities included launching trade and tourism promotions, meeting local officials, businesses and overseas Vietnamese to introduce trade and investment opportunities in Vietnam. Ms. Nguyen's expertise includes all sectors of the economy (import-export, public service, textiles and manufacturing, real estate, technology, and retail and wholesale). She is fluent in English, Vietnamese, French and Mandarin and conversational in Russian. "We are pleased to welcome Ms. Nguyen to our Advisory Board," said Patricia Traczykowski, President of MDCE. "Her insights and access to the Vietnam market for our technology, products and services will be valuable as MDCE plans to expand and grow the Company in other markets outside of China. We look forward to working with her." About Medical Care Technologies, Inc. Medical Care Technologies, Inc. ( ) is traded under the symbol MDCE on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended will constitute a healthcare delivery and wellness site; dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business, technology and information systems to assist the Asian health industry -- physicians, pharmacists, medical institutions, consumers -- access medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutriceuticals. Further information on the Company can be found at and the company's website at Safe Harbor Statement All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding: MDCE's products, services, capabilities, performance, opportunities, development and business outlook, guidance on our future financial results and other projections or measures of our future performance; the amount and timing of the benefits expected from strategic initiatives and acquisitions or from deployment of new or updated technologies, products, services or applications; and other potential sources of additional revenue. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: lack of operating history, transitioning from a development company to an operating company, difficulties in distinguishing MDCE's products and services, ability to deploy MDCE's services and products, market acceptance of our products and services; operational difficulties relating to combining acquired companies and businesses; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and healthcare and pharmaceutical industries, and our ability to attract and retain qualified personnel. Other risks and uncertainties may include, but are not limited to: lack of or delay in market acceptance and fluctuations in customer demand, dependence on a limited number of significant customers, reliance on third party vendors and strategic partners, ability to meet future capital requirements on acceptable terms, continuing uncertainty in the global economy, and compliance with federal and state regulatory requirement. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements. There can be no assurance that the acquisition of GUC's assets will close. MDCE must issue 57,300,000 shares of its common stock to GUC, or GUC's designees in order to close the acquisition. Accounting for the anticipated cancelation of 57,300,000 shares by Patricia Traczykowski, MDCE will have 98,900,000 shares of its common stock issued and outstanding upon the closing of the acquisition. For Further Information: Ezra Smith C. Jones Consulting, Inc. Tel: (727) 771-9500 Fax: (727) 771-9545 Email: cjones@cjonesconsulting.com Web: